TARO-BUPROPION XL, Tablets
« Back to list view

Product Information

  • DIN:
    02475804
  • Active Ingredients :
    bupropion hydrochloride
  • Innovator Name:
    Wellbutrin®XL
  • Category:
    Antidepressant
  • Dosage form:
    Tablets, Extended-Release
  • Strength:
    150 mg
  • Package size:
    90 Bottle 500 Bottle
  • UPC Code:
    876515005874 876515005881
  • Non-medicinal ingredients :
    ethylcellulose, glyceryl behenate, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, methylacrylic acid- copolymer dispersion, polyethylene glycol, povidone, propylene glycol, shellac glaze, silicon dioxide, stearic acid, and triethyl citrate
TARO-BUPROPION XL, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02475812
  • Active Ingredients :
    bupropion hydrochloride
  • Innovator Name:
    Wellbutrin®XL
  • Category:
    Antidepressant
  • Dosage form:
    Tablets, Extended-Release
  • Strength:
    300 mg
  • Package size:
    90 Bottle 500 Bottle
  • UPC Code:
    876515005898 876515005904
  • Non-medicinal ingredients :
    ethylcellulose, glyceryl behenate, hydroxypropyl cellulose, hypromellose, iron oxide black, lactose monohydrate, methylacrylic acid- copolymer dispersion, polyethylene glycol, povidone, propylene glycol, shellac glaze, silicon dioxide, stearic acid, and triethyl citrate
TARO-BUPROPION XL, Tablets

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here